180 related articles for article (PubMed ID: 24307243)
1. IL-4-induced gene 1 maintains high Tob1 expression that contributes to TCR unresponsiveness in human T helper 17 cells.
Santarlasci V; Maggi L; Mazzoni A; Capone M; Querci V; Rossi MC; Beltrame L; Cavalieri D; De Palma R; Liotta F; Cosmi L; Maggi E; Romagnani S; Annunziato F
Eur J Immunol; 2014 Mar; 44(3):654-61. PubMed ID: 24307243
[TBL] [Abstract][Full Text] [Related]
2. Better safe than sorry: TOB1 employs multiple parallel regulatory pathways to keep Th17 cells quiet.
Salerno F; van Lier RA; Wolkers MC
Eur J Immunol; 2014 Mar; 44(3):646-9. PubMed ID: 24497109
[TBL] [Abstract][Full Text] [Related]
3. Reasons for rarity of Th17 cells in inflammatory sites of human disorders.
Annunziato F; Santarlasci V; Maggi L; Cosmi L; Liotta F; Romagnani S
Semin Immunol; 2013 Nov; 25(4):299-304. PubMed ID: 24211040
[TBL] [Abstract][Full Text] [Related]
4. Degradation of Tob1 mediated by SCFSkp2-dependent ubiquitination.
Hiramatsu Y; Kitagawa K; Suzuki T; Uchida C; Hattori T; Kikuchi H; Oda T; Hatakeyama S; Nakayama KI; Yamamoto T; Konno H; Kitagawa M
Cancer Res; 2006 Sep; 66(17):8477-83. PubMed ID: 16951159
[TBL] [Abstract][Full Text] [Related]
5. Rarity of human T helper 17 cells is due to retinoic acid orphan receptor-dependent mechanisms that limit their expansion.
Santarlasci V; Maggi L; Capone M; Querci V; Beltrame L; Cavalieri D; D'Aiuto E; Cimaz R; Nebbioso A; Liotta F; De Palma R; Maggi E; Cosmi L; Romagnani S; Annunziato F
Immunity; 2012 Feb; 36(2):201-14. PubMed ID: 22326581
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of the immunosuppressive enzyme IL4I1 in human induced Aiolos+, but not natural Helios+, FOXP3+ Treg cells.
Scarlata CM; Celse C; Pignon P; Ayyoub M; Valmori D
Eur J Immunol; 2015 Feb; 45(2):474-9. PubMed ID: 25446972
[TBL] [Abstract][Full Text] [Related]
7. TOB1 Blocks Intestinal Mucosal Inflammation Through Inducing ID2-Mediated Suppression of Th1/Th17 Cell Immune Responses in IBD.
Lin R; Ma C; Fang L; Xu C; Zhang C; Wu X; Wu W; Zhu R; Cong Y; Liu Z
Cell Mol Gastroenterol Hepatol; 2022; 13(4):1201-1221. PubMed ID: 34920145
[TBL] [Abstract][Full Text] [Related]
8. IL4I1: Key immunoregulator at a crossroads of divergent T-cell functions.
Romagnani S
Eur J Immunol; 2016 Oct; 46(10):2302-2305. PubMed ID: 27726138
[TBL] [Abstract][Full Text] [Related]
9. The Shc family protein adaptor, Rai, acts as a negative regulator of Th17 and Th1 cell development.
Savino MT; Ulivieri C; Emmi G; Prisco D; De Falco G; Ortensi B; Beccastrini E; Emmi L; Pelicci G; D'Elios MM; Baldari CT
J Leukoc Biol; 2013 Apr; 93(4):549-59. PubMed ID: 23345394
[TBL] [Abstract][Full Text] [Related]
10. An Overview of l-Amino Acid Oxidase Functions from Bacteria to Mammals: Focus on the Immunoregulatory Phenylalanine Oxidase IL4I1.
Castellano F; Molinier-Frenkel V
Molecules; 2017 Dec; 22(12):. PubMed ID: 29206151
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of TOB1 confers radioprotection to bronchial epithelial cells through the MAPK/ERK pathway.
Che J; Lu YW; Sun KK; Feng C; Dong AJ; Jiao Y
Oncol Rep; 2013 Aug; 30(2):637-42. PubMed ID: 23756562
[TBL] [Abstract][Full Text] [Related]
12. Distinctive features of classic and nonclassic (Th17 derived) human Th1 cells.
Maggi L; Santarlasci V; Capone M; Rossi MC; Querci V; Mazzoni A; Cimaz R; De Palma R; Liotta F; Maggi E; Romagnani S; Cosmi L; Annunziato F
Eur J Immunol; 2012 Dec; 42(12):3180-8. PubMed ID: 22965818
[TBL] [Abstract][Full Text] [Related]
13. TOB1 is regulated by EGF-dependent HER2 and EGFR signaling, is highly phosphorylated, and indicates poor prognosis in node-negative breast cancer.
Helms MW; Kemming D; Contag CH; Pospisil H; Bartkowiak K; Wang A; Chang SY; Buerger H; Brandt BH
Cancer Res; 2009 Jun; 69(12):5049-56. PubMed ID: 19491269
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-590 promotes pathogenic Th17 cell differentiation through targeting Tob1 and is associated with multiple sclerosis.
Liu Q; Gao Q; Zhang Y; Li Z; Mei X
Biochem Biophys Res Commun; 2017 Nov; 493(2):901-908. PubMed ID: 28947212
[TBL] [Abstract][Full Text] [Related]
15. Defining the human T helper 17 cell phenotype.
Annunziato F; Cosmi L; Liotta F; Maggi E; Romagnani S
Trends Immunol; 2012 Oct; 33(10):505-12. PubMed ID: 22682163
[TBL] [Abstract][Full Text] [Related]
16. The role of retinoic acid-related orphan receptor variant 2 and IL-17 in the development and function of human CD4+ T cells.
Crome SQ; Wang AY; Kang CY; Levings MK
Eur J Immunol; 2009 Jun; 39(6):1480-93. PubMed ID: 19449310
[TBL] [Abstract][Full Text] [Related]
17. Th17 cell development: from the cradle to the grave.
Zúñiga LA; Jain R; Haines C; Cua DJ
Immunol Rev; 2013 Mar; 252(1):78-88. PubMed ID: 23405896
[TBL] [Abstract][Full Text] [Related]
18. Repression of anti-proliferative factor Tob1 in osteoarthritic cartilage.
Gebauer M; Saas J; Haag J; Dietz U; Takigawa M; Bartnik E; Aigner T
Arthritis Res Ther; 2005; 7(2):R274-84. PubMed ID: 15743474
[TBL] [Abstract][Full Text] [Related]
19. CD4 T cell-intrinsic IL-2 signaling differentially affects Th1 and Th17 development.
Fujimura K; Oyamada A; Iwamoto Y; Yoshikai Y; Yamada H
J Leukoc Biol; 2013 Aug; 94(2):271-9. PubMed ID: 23715742
[TBL] [Abstract][Full Text] [Related]
20. IFN-γ and IL-12 synergize to convert in vivo generated Th17 into Th1/Th17 cells.
Lexberg MH; Taubner A; Albrecht I; Lepenies I; Richter A; Kamradt T; Radbruch A; Chang HD
Eur J Immunol; 2010 Nov; 40(11):3017-27. PubMed ID: 21061434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
